(Q42986816)

12 November 2017

Baseline level and early suppression of serum HCV RNA for predicting sustained complete response to alpha-interferon therapy (English)

1 reference

12 November 2017

Izopet J

1

1 reference

12 November 2017

Payen JL

2

1 reference

12 November 2017

Alric L

3

1 reference

12 November 2017

Sandres K

4

1 reference

12 November 2017

Charlet JP

5

1 reference

12 November 2017

Vinel JP

6

1 reference

12 November 2017

Duffaut M

7

1 reference

12 November 2017

Pascal JP

8

1 reference

12 November 2017

Puel J

9

1 reference

12 November 2017

1 February 1998

1 reference

Journal of Medical Virology

12 November 2017

1 reference

12 November 2017

54

1 reference

12 November 2017

2

1 reference

12 November 2017

86-91

1 reference

Persistent hepatitis C viremia predicts late relapse after sustained response to interferon-alpha in chronic hepatitis C. TriVeneto Viral Hepatitis Group

12 November 2017

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199802%2954%3A2%3C86%3A%3AAID-JMV3%3E3.0.CO%3B2-K

Significance of serum hepatitis C virus RNA levels in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199802%2954%3A2%3C86%3A%3AAID-JMV3%3E3.0.CO%3B2-K

Implications of variations of "conserved" regions of hepatitis C virus genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199802%2954%3A2%3C86%3A%3AAID-JMV3%3E3.0.CO%3B2-K

Distribution of hepatitis C virus genotypes determined by line probe assay in patients with chronic hepatitis C seen at tertiary referral centers in the United States. Hepatitis Interventional Therapy Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199802%2954%3A2%3C86%3A%3AAID-JMV3%3E3.0.CO%3B2-K

Serum hepatitis C virus RNA level as a predictor of subsequent response to interferon-alpha therapy in Japanese patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199802%2954%3A2%3C86%3A%3AAID-JMV3%3E3.0.CO%3B2-K

Factors affecting treatment responses to interferon-alpha in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199802%2954%3A2%3C86%3A%3AAID-JMV3%3E3.0.CO%3B2-K

Hepatic hepatitis C virus RNA as a predictor of a long-term response to interferon-alpha therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199802%2954%3A2%3C86%3A%3AAID-JMV3%3E3.0.CO%3B2-K

Levels of hepatitis C virus in blood donors infected with different viral genotypes. International HCV Collaborative Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199802%2954%3A2%3C86%3A%3AAID-JMV3%3E3.0.CO%3B2-K

Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199802%2954%3A2%3C86%3A%3AAID-JMV3%3E3.0.CO%3B2-K

Clinical outcomes after transfusion-associated hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199802%2954%3A2%3C86%3A%3AAID-JMV3%3E3.0.CO%3B2-K

Detection of hepatitis C virus by polymerase chain reaction and response to interferon-alpha therapy: relationship to genotypes of hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199802%2954%3A2%3C86%3A%3AAID-JMV3%3E3.0.CO%3B2-K

Phylogenetic analysis of hepatitis C virus isolates and their correlation to viremia, liver function tests, and histology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199802%2954%3A2%3C86%3A%3AAID-JMV3%3E3.0.CO%3B2-K

A proposed system for the nomenclature of hepatitis C viral genotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199802%2954%3A2%3C86%3A%3AAID-JMV3%3E3.0.CO%3B2-K

Chronic viral hepatitis--benefits of current therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199802%2954%3A2%3C86%3A%3AAID-JMV3%3E3.0.CO%3B2-K

Hepatitis C virus genotypes 1 and 2 respond to interferon-alpha with different virologic kinetics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199802%2954%3A2%3C86%3A%3AAID-JMV3%3E3.0.CO%3B2-K

10.1002/(SICI)1096-9071(199802)54:2<86::AID-JMV3>3.0.CO;2-K

21 January 2018

Identifiers

DOI

1 reference

12 November 2017

1 reference